Cornejo-Moreno Borys A, Uribe-Escamilla Diego, Salamanca-Gómez Fabio
Isr Med Assoc J. 2014 Dec;16(12):787-92.
Breast cancer, specifically mammary carcinoma, is the most common cause of death from cancer in women worldwide, with a lifetime risk of one in nine, and its prevalence is increasing. It represents around 30% of all cancer in females and approximately 40,000 deaths in the United States per year. Important advances have been made in detection and treatment, but a significant number of breast cancers are still detected late. This summary of its epidemiology and history, the molecular aspects of detection and the main implicated genes emphasizes the etiology and heterogeneity of the disease. It is still not clear whether the remaining cases of breast cancer negative to BRCA are due to mutations in another high penetrance gene or to unknown factors yet to be discovered.
乳腺癌,尤其是乳腺导管癌,是全球女性癌症死亡的最常见原因,终生患病风险为九分之一,且其发病率正在上升。它约占女性所有癌症的30%,在美国每年约有4万人死亡。在检测和治疗方面已取得重要进展,但仍有大量乳腺癌发现时已处于晚期。本文对其流行病学、历史、检测的分子层面以及主要相关基因进行总结,强调了该疾病的病因和异质性。目前仍不清楚BRCA阴性的其余乳腺癌病例是由于另一个高外显率基因的突变,还是由于尚未发现的未知因素。